V013-2268 Screening compound: 2,4-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-1,3-thiazol-2-yl)benzamide

V013-2268 Screening compound: 2,4-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-1,3-thiazol-2-yl)benzamide
V013-2268 Screening compound: 2,4-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-1,3-thiazol-2-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V013-2268
2,4-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-1,3-thiazol-2-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V013-2268

Molecular Formula

C20H25Cl2N5O2S (C20 H25 Cl2 N5 O2 S)

Compound Name

2,4-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-1,3-thiazol-2-yl)benzamide

IUPAC name

24-dichloro-N-(4-{4-[3-(dimethylamino)propyl]piperazine-1-carbonyl}-13-thiazol-2-yl)benzamide

SMILES

CN(C)CCCN(CC1)CCN1C(c1csc(NC(c(ccc(Cl)c2)c2Cl)=O)n1)=O

InChI

InChI=1S/C20H25Cl2N5O2S/c1-25(2)6-3-7-26-8-10-27(11-9-26)19(29)17-13-30-20(23-17)24-18(28)15-5-4-14(21)12-16(15)22/h4-5,12-13H,3,6-11H2,1-2H3,(H,23,24,28)

InChI Key

DVZHCLTXZAIVNF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19976287

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

470.42

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.074

Distribution Coefficient, logD

3.074

Water Solubility, LogSw

-3.73

Polar Surface Area

57.680

Acid Dissociation Constant (pKa)

6.41

Base Dissociation Constant (pKb)

8.94

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.00

V013-2268 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • GPCR
  • Ion Channels
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V013-2268 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V013-2268?
Check Price and Availability of V013-2268, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V013-2268 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V013-2268
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V013-2268
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V013-2268 available by request